Allarity Therapeutics, Inc.
ALLR
$1.28
$0.032.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 25.00K | 320.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 25.00K | 320.00K | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 25.00K | 320.00K | -- | -- |
| SG&A Expenses | 1.33M | 1.42M | 1.56M | 1.32M | 1.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -833.00K | -- | -- |
| Total Operating Expenses | 2.67M | 2.71M | 3.24M | 2.52M | 4.13M |
| Operating Income | -2.67M | -2.69M | -2.92M | -2.52M | -4.13M |
| Income Before Tax | -3.41M | -2.75M | -3.37M | -2.81M | -2.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.41M | -2.75M | -3.37M | -2.81M | -2.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.41M | -2.75M | -3.37M | -2.81M | -2.32M |
| EBIT | -2.67M | -2.69M | -2.92M | -2.52M | -4.13M |
| EBITDA | -2.64M | -- | -2.91M | -2.51M | -4.12M |
| EPS Basic | -0.21 | -0.17 | -0.21 | -0.19 | -0.15 |
| Normalized Basic EPS | -0.13 | -0.11 | -0.13 | -0.12 | -0.09 |
| EPS Diluted | -0.21 | -0.17 | -0.21 | -0.19 | -0.15 |
| Normalized Diluted EPS | -0.13 | -0.11 | -0.13 | -0.12 | -0.09 |
| Average Basic Shares Outstanding | 15.91M | 15.97M | 15.97M | 14.74M | 15.54M |
| Average Diluted Shares Outstanding | 15.91M | 15.97M | 15.97M | 14.74M | 15.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |